Talking Medicines : Driving more Effective Medicines By Listening to Patient
July 9, 2020

Founders Jo Halliday, CEO and Elizabeth Fairley, COO of Talking Medicines recently collaborated with a US pharma trade publication based out of New York called pharma’s almanac. The article published articulates their views on the opportunities for marketing in pharma companies to use the Talking Medicines patient intelligence to measure their performance and identify strategies for improvement.

pharma's almanac

Talking Medicines feature in pharma’s almanac

 

The voice of the patient has long been underserved in the pharmaceutical industry, despite extensive evidence that listening to patients and learning about their experiences can dramatically improve drug development, delivery, and accessibility, as well as patient support. The platform technology developed by Talking Medicines is designed to report on marketing intelligence for medicines, gathering information about patient experiences with existing drugs to help pharma companies identify barriers to access and opportunities for growth, and to provide enhanced support for optimized health outcomes.

The full article can be found here 

July 2020

 

Recent Blogs

The impact of coronavirus on ethnic minorities

The impact of coronavirus on ethnic minorities

Over the last few months we have seen an alarming number of deaths in ethnic minority groups due to coronavirus. In fact, the figures show that the death rate for Black and Asian people is four and three times greater respectively than for White people (Public Health...

How have we been lending a hand to the COVID-19 effort?

How have we been lending a hand to the COVID-19 effort?

COVID-19 is undoubtedly having an impact on patient populations. During this challenging time, Talking Medicines have been doing their bit to support the Medsmart® community whilst sharing data insight from greater patient populations to add value to Government data,...

Week 9 of government advised lockdown: COVID-19 survey update

Week 9 of government advised lockdown: COVID-19 survey update

Talking Medicines have now captured 1,827 responses across five surveys showing the public opinions to COVID-19. Outreach engagement is via direct Facebook from the Medsmart® community to understand the attitudes, views and behaviour changes in the community towards...

COVID-19 – Why the gender disparity?

COVID-19 – Why the gender disparity?

Over the last few weeks there has been a lot of speculation over what exacerbates an individual’s response to coronavirus and why there is such great disparity in the gender of those dying from this virus. One explanation being explored is the effect of Angiotensin...